Estrogens, conjugated
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
3575 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 276 | 725 | 323 | 50 | 255 | 1516 |
| Infertility | D007246 | HP_0000789 | — | 14 | 28 | 40 | 58 | 79 | 204 |
| Neoplasms | D009369 | — | C80 | 62 | 56 | 17 | 3 | 20 | 139 |
| Carcinoma | D002277 | — | C80.0 | 20 | 66 | 24 | 3 | 19 | 125 |
| Syndrome | D013577 | — | — | 8 | 26 | 25 | 30 | 41 | 125 |
| Menopause | D008593 | EFO_0003922 | N95 | 18 | 22 | 22 | 29 | 34 | 120 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 8 | 12 | 29 | 31 | 43 | 118 |
| Healthy volunteers/patients | — | — | — | 88 | 8 | 5 | 4 | 14 | 114 |
| Triple negative breast neoplasms | D064726 | — | — | 35 | 53 | 8 | 2 | 4 | 89 |
| Postmenopause | D017698 | — | — | 16 | 24 | 20 | 11 | 20 | 85 |
Show 217 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 11 | 45 | 19 | — | 10 | 79 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 10 | 41 | 7 | — | 9 | 59 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 16 | 35 | 9 | — | 3 | 57 |
| Carcinoma in situ | D002278 | — | D09.9 | 4 | 23 | 6 | — | 6 | 38 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 9 | 22 | 9 | — | — | 37 |
| Intraductal carcinoma noninfiltrating | D002285 | — | D05.1 | 3 | 20 | 4 | — | 4 | 30 |
| Ductal carcinoma | D044584 | — | — | 7 | 16 | 3 | — | 1 | 24 |
| Coronary disease | D003327 | — | — | — | 3 | 12 | — | 5 | 18 |
| Lobular carcinoma | D018275 | EFO_0000570 | — | 2 | 9 | 1 | — | 6 | 18 |
| Arthralgia | D018771 | HP_0002829 | M25.5 | — | 5 | 3 | — | 11 | 18 |
Show 107 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 12 | 9 | — | — | 1 | 18 |
| Tissue adhesions | D000267 | — | — | 3 | 1 | — | — | 10 | 13 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 8 | 7 | — | — | — | 12 |
| Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | 1 | 10 | — | — | — | 10 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 4 | — | — | 2 | 9 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 4 | — | — | 4 | 8 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 5 | 1 | — | — | 2 | 8 |
| Inflammation | D007249 | MP_0001845 | — | 2 | 5 | — | — | 3 | 8 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | 3 | — | — | 1 | 6 |
| Central nervous system neoplasms | D016543 | — | — | 1 | 6 | — | — | — | 6 |
Show 181 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | — | — | 11 | — | — | — | 1 | 12 |
| Drug interactions | D004347 | — | — | 4 | — | — | — | 2 | 6 |
| Hepatitis c | D006526 | — | B19.2 | 5 | — | — | — | — | 5 |
| Arthritis | D001168 | HP_0001369 | M05-M14 | 1 | — | — | — | 3 | 4 |
| Headache | D006261 | HP_0002315 | R51 | 1 | — | — | — | 3 | 4 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | 2 | 3 |
| Kallmann syndrome | D017436 | Orphanet_478 | E23.0 | 1 | — | — | — | 2 | 3 |
| Hyperinsulinism | D006946 | HP_0000842 | E16.1 | 1 | — | — | — | 2 | 3 |
| Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 3 | — | — | — | — | 3 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | — | — | — | 1 | 2 |
Show 45 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Menstrual cycle | D008597 | — | — | — | — | — | — | 6 | 6 |
| Eclampsia | D004461 | HP_0100601 | O15 | — | — | — | — | 3 | 3 |
| Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 3 | 3 |
| Lichen sclerosus et atrophicus | D018459 | — | L90.0 | — | — | — | — | 3 | 3 |
| Gender identity | D005783 | — | — | — | — | — | — | 3 | 3 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 2 | 2 |
| Pregnancy rate | D018873 | — | — | — | — | — | — | 2 | 2 |
| Feeding behavior | D005247 | — | — | — | — | — | — | 2 | 2 |
| Cerebrospinal fluid leak | D065634 | — | G96.0 | — | — | — | — | 2 | 2 |
| Glucose metabolism disorders | D044882 | — | — | — | — | — | — | 2 | 2 |
Show 143 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 72,284 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
61,956 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use